Tag: CFSRE

Recommended Scope for NPS Testing in the United States: Q1 2023

Posted on By Becky Carter

Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefson, Elisa Shoff, Szabolcs Sofalvi, Svanto Vikingsson, Michael Truver, Celia Modoll, and Barry Logan

SOFT, CFSRE; February 2023

Access article

Cannabis and Cannabinoids, Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

ToxIC Fentalog Study Group – Quarterly NPS Report – Q3

Posted on By sdargoltz

Alex Manini, MD; Alex J Krotulski, PhD; Sara E. Walton, MS; Paul Wax, MD; Jeffery Brent, MD, PhD; Kim Aldy, DO; Alexandra Amaducci, DO; Dlane Calello, MD; Adrienne Hughes, MD; Anthony Pizon, MD; Michael Levine, MD; Evan Schwarz, MD; Bryan Judge, MD; and Barry K. Logan, PhD, F-ABFT

CSFRE; TIC; ACMT; October 2022

Access article

Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Sexual Assault / SANE, Statistics and Data Analysis, Toxicology

NPS Discovery Toolkit: N-Pyrrolidino Etonitazene

Posted on By sdargoltz

Sara E. Walton, MS; Alex J. Krotulski, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Donna M. Papsun, MS, D-ABFT; and Barry K. Logan, PhD, F-ABFT

CFSRE; October 2022

Access article

Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Sexual Assault / SANE, Toxicology

Recommended Scope for NPS Testing in the United States: Q2 2022

Posted on By sdargoltz

Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Kevin Shanks, Szabolcs Sofalvi, Wayne Lewallen, Svante Vikingsson, and Barry Logan

CFSRE; July 2022

Access article

Cannabis and Cannabinoids, Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids – Q2 2022 Trend Reports

Posted on By sdargoltz

Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

CFSRE; July 13, 2022

Access article

Cannabis and Cannabinoids, Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

Bromazolam Prevalence Surging Across the United States Driven In Part by Increasing Detections Alongside Fentanyl

Posted on By sdargoltz

Donna M. Papsun, MS, D-ABFT-FT; Alex J. Krotulski, PhD; Rebecca Mastrovito, MS; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; June 15, 2022

Access article

Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

Drug Checking (Q2 2022): Philadelphia, Pennsylvania, USA

Posted on By Becky Carter

Alex J. Krotulski, PhD; Jen Shinefeld, MS; Jeffrey Hom, MD, MPH; Sara E. Walton, BS; Joshua DeBord, PhD; Barry K. Logan, PhD, F-ABFT

CFSRE; June 7, 2022

Access article

Cannabis and Cannabinoids, Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

Recommended Scope for NPS Testing in the United States – Q1 2022

Posted on By Becky Carter

Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Kevin Shanks, Szabolcs Sofalvi, Wayne Lewallen, Svante Vikingsson, and Barry Logan

CFSRE; May 12, 2022

Access article

Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replaces Eutylone in Drug Supply Typically Sold as “Ecstasy” or “Molly”

Posted on By Becky Carter

Alex J. Krotulski, PhD; Melissa F. Fogarty, MS, D-ABFT-FT; Donna M. Papsun, MS, D-ABFT-FT; Michael Lamb, MS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; April 2022

Access article

Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

Drug Checking Report – Q1 2022: Philadelphia, Pennsylvania, USA

Posted on By Becky Carter

Alex J. Krotulski, PhD; Jen Shinefeld, MS; Jeffrey Hom, MD, MPH; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CSFRE; March 22, 2022

Access article

Cannabis and Cannabinoids, Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

Adverse Effects Linked to Next Generation Opioids Reported in Patients Presenting to Emergency Departments After Suspected Opioid Overdose

Posted on By Becky Carter

Alex Manini, MD; Alex J. Krotulski, PhD; Sara E. Walton, MS; Paul Wax, MD; Jeffery Brent, MD, PhD; Kim Aldy, DO; Diane Calello, MD; Alexandra Amaducci, DO; Evan Schwarz, MD; Bryan Judge, MD; Michael Levine, MD; Barry K. Logan, PhD, F-ABFT

Center for Forensic Science Research and Education; December 3, 2021

Read announcement

Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology